We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Pinnacle West Capital
PNW
$11.8B
| $109M | 0.15% |
1,020,983
+674,200
| +194% | +$68.9M |
|
127
Dominion Energy
D
$57.3B
| $108M | 0.15% |
+1,583,811
| New | +$103M |
|
|
JBTM
128
JBT Marel
JBTM
$5.91B
| $108M | 0.15% |
742,219
+188,795
| +34% | +$24.4M |
|
129
Altria Group
MO
$113B
| $107M | 0.15% |
1,488,332
-15,500
| -1% | -$1.08M |
|
130
Datadog
DDOG
$80.9B
| $105M | 0.15% |
404,800
-39,300
| -9% | -$7.31M |
|
131
Progressive
PGR
$125B
| $105M | 0.15% |
480,785
-29,300
| -6% | -$5.91M |
|
132
Parker-Hannifin
PH
$120B
| $104M | 0.15% |
106,368
-39,700
| -27% | -$36.4M |
|
133
Fortune Brands Innovations
FBIN
$4.86B
| $103M | 0.15% |
1,883,271
-524,265
| -22% | -$21M |
|
|
SCHW
134
Charles Schwab
SCHW
$184B
| $103M | 0.14% |
1,117,039
-549,300
| -33% | -$50.1M |
|
135
TE Connectivity
TEL
$59.3B
| $103M | 0.14% |
510,144
+97,300
| +24% | +$20.7M |
|
136
Entergy
ETR
$51.2B
| $101M | 0.14% |
881,104
-127,100
| -13% | -$14.3M |
|
137
IDEAYA Biosciences
IDYA
$3.7B
| $101M | 0.14% |
2,715,391
-108,109
| -4% | -$3.31M |
|
138
General Dynamics
GD
$95.4B
| $101M | 0.14% |
285,248
+38,207
| +15% | +$13.1M |
|
139
Dell
DELL
$346B
| $100M | 0.14% |
232,800
+21,600
| +10% | +$6.25M |
|
140
CSX Corp
CSX
$89.6B
| $100M | 0.14% |
2,108,426
-4,977,107
| -70% | -$225M |
|
141
Bristol-Myers Squibb
BMY
$132B
| $98.9M | 0.14% |
1,716,000
+249,329
| +17% | +$14.3M |
|
142
Keurig Dr Pepper
KDP
$43.7B
| $97.3M | 0.14% |
2,972,600
+1,755,500
| +144% | +$51.1M |
|
143
Takeda Pharmaceutical
TAK
$58.2B
| $97M | 0.14% |
6,050,771
-374,213
| -6% | -$6.19M |
|
144
Stryker
SYK
$106B
| $96.8M | 0.14% |
+307,499
| New | +$96.9M |
|
145
Phillips 66
PSX
$104B
| $96.7M | 0.14% |
572,301
-208,700
| -27% | -$35.9M |
|
146
Howmet Aerospace
HWM
$92.8B
| $95.9M | 0.13% |
356,600
+77,291
| +28% | +$19.8M |
|
147
Scholar Rock
SRRK
$6.65B
| $95.2M | 0.13% |
1,731,402
+1,031,402
| +147% | +$49.8M |
|
148
Quanta Services
PWR
$94.3B
| $94.9M | 0.13% |
131,791
+5,200
| +4% | +$3.55M |
|
|
LBRDK
149
DELISTED
Liberty Broadband Class C
LBRDK
| $94.3M | 0.13% |
2,835,384
+401,717
| +17% | +$15.7M |
|
150
O'Reilly Automotive
ORLY
$69.6B
| $93.3M | 0.13% |
1,013,600
+367,400
| +57% | +$33.5M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.